麝香保心丸联合单硝酸异山梨酯治疗冠心病临床研究
DOI:
CSTR:
作者:
作者单位:

作者简介:

通讯作者:

中图分类号:

R541.4

基金项目:


Clinical Study on Shexiang Baoxin Pills Combined with Isosorbide Mononitrate for Coronary Heart Disease
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    目的:观察麝香保心丸联合单硝酸异山梨酯治疗冠心病的临床疗效。方法:选取126 例冠心病患者,根据随机数字表法分为对照组和观察组,每组63 例。对照组给予单硝酸异山梨酯缓释片治疗,观察组在对照组基础上给予麝香保心丸治疗,2 组均治疗2 个月。比较2 组临床疗效;比较2 组治疗前后心绞痛发作情况、冠状动脉血流情况及血脂水平。结果:治疗后,2 组心绞痛发作频率均较治疗前降低(P<0.05),心绞痛持续时间均较治疗前缩短(P<0.05);观察组心绞痛发作频率低于对照组(P<0.05),心绞痛持续时间短于对照组(P<0.05)。治疗后,2 组冠状动脉收缩期峰值流速、舒张期峰值流速均较治疗前增大(P<0.05);观察组冠状动脉收缩期峰值流速、舒张期峰值流速均大于对照组(P<0.05)。治疗后,2 组总胆固醇(TC)、甘油三酯(TG)、低密度脂蛋白(LDL) 水平均较治疗前降低(P<0.05),高密度脂蛋白(HDL) 水平均较治疗前升高(P<0.05);观察组TC、TG、LDL 水平均低于对照组(P<0.05),HDL 水平高于对照组(P<0.05)。经秩和检验,观察组临床疗效优于对照组(P<0.05)。结论:麝香保心丸联合单硝酸异山梨酯治疗冠心病有助于减轻患者的心绞痛发作情况,改善其冠状动脉血流,调节血脂水平。

    Abstract:

    Abstract: Objective: To observe the clinical effect of Shexiang Baoxin pills combined with isosorbide mononitrate for coronary heart disease. Methods:A total of 126 cases of patients with coronary heart disease were selected and divided into the control group and the observation group according to the random number table method,with 63 cases in each group. The control group was treated with isosorbide mononitrate sustained release tablets,and the observation group was additionally treated with Shexiang Baoxin pills based on the treatment of the control group. Both groups were treated for two months. The angina attacks,coronary artery flow and blood lipid levels before and after treatment as well as the clinical effects in the two groups were compared. Results:After treatment,the frequency of angina attacks in the two groups was decreased when compared with that before treatment(P<0.05),and the duration of angina pectoris was shortened(P<0.05);the frequency of angina attacks in the observation group was lower than that in the control group(P<0.05), and the duration of angina pectoris was shorter(P<0.05). After treatment,peak systolic velocity and peak diastolic velocity of coronary artery in the two groups were increased when compared with those before treatment(P<0.05); peak systolic velocity and peak diastolic velocity of coronary artery in the observation group were higher than those in the control group(P<0.05). After treatment,the levels of total cholesterol(TC), triglyceride(TG) and low density lipoprotein(LDL) in the two groups were decreased when compared with those before treatment(P<0.05), and the levels of high density lipoprotein(HDL) were increased(P<0.05); the levels of TC,TG and LDL in the observation group were lower than those in the control group(P<0.05),and HDL level was higher(P<0.05). The clinical effect in the observation group was better than that in the control group(P<0.05). Conclusion: The therapy of Shexiang Baoxin pills combined with isosorbide mononitrate for coronary heart disease can alleviate angina attacks,improve coronary artery flow,and regulate blood lipid levels.

    参考文献
    相似文献
    引证文献
引用本文

俞竹青,刘峰,叶旦阳.麝香保心丸联合单硝酸异山梨酯治疗冠心病临床研究[J].新中医,2022,54(2):38-41

复制
分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2022-01-22
  • 出版日期:
文章二维码